Intranasal administration of the dopaminergic agonists L-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: A microdialysis study in the rat

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 233-239

  De Souza Silva, M A ^a   Mattern, C ^b   Hacker R ^b   Nogueira, P J C ^a   Huston, J P ^a   Schwarting, R K W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Mattern et Partner   (Germany)

Author keywords

Addiction; Basal ganglia; L DOPA; Microdialysis; Parkinson's disease; Pharmacokinetics; Psychostimulants

Indexed keywords

COCAINE; DEXAMPHETAMINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; HOMOVANILLIC ACID; LEVODOPA;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; INTRANASAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NEOSTRIATUM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031037193     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010233.x     Document Type: Article

References (40)

1. Adams F., Schwarting R. K. W., Boix F., and Huston J. P. (1991) Lateralized changes in behavior and striatal dopamine release following unilateral tactile stimulation of the perioral region: a microdialysis study. Brain Res. 553, 318-322.
2. Akimoto K., Hamamura T., and Otsuki S. (1989) Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis. Brain Res. 490, 339-344.
3. Baker H. and Spencer R. F. (1986) Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. Exp. Brain Res. 63, 461-473.
4. Balin B. J., Broadwell R. D., Salcman M., and El-Kalliny M. (1986) Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J. Comp. Neurol. 251, 260-280.
5. Boix F., Mattioli R., Adams F., Huston J. P., and Schwarting R. K. W. (1993) Peripherally administered substance P affects extracellular dopamine concentrations in the neostriatum but not in the nucleus accumbens under anesthesia. Brain Res. Bull 31, 655-660.
6. Boix F., Pfister M., Huston J. P., and Schwarting R. K. W. (1994) Substance P decreases extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens in vivo: possible relevance for the central processing of reward and aversion. Behav. Brain Res. 63, 213-219.
7. Brannan T., Knott P., Kaufmann H., Leung L., and Yahr M. (1989) Intracerebral monitoring of striatal dopamine release and metabolism in response to 1-DOPA. J. Neural Transm. 75, 149-157.
8. Chien Y. W., Su K. S. E., and Chang S.-F. (1989) Nasal Systemic Drug Delivery. Marcel Dekker, New York.
9. Church W. H., Justice J. B. Jr., and Byrd L. D. (1987) Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur. J. Pharmacol. 139, 345-348.
10. Di Chiara G. and Imperato A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85, 5274-5278.
11. Gopinath P. G., Gopinath G., and Kumar T. C. (1978) Target site of intranasally sprayed substances and their transport across the nasal mucosa: a new insight into the intranasal route of drug-delivery. Curr. Ther. Res. Clin. Exp. 23, 596-607.
12. Hastings L. and Evans J. E. (1991) Olfactory primary neurons as a route of entry for toxic agents into the CNS. Neurotoxicology 12, 707-714.
13. Hirai S., Yashiki T., and Mima H. (1981) Effect of surfactants on the nasal absorption of insulin in rats. Int. J. Pharm. 9, 165-172.
14. Hussain M. A., Rakestraw D., Rowe S., and Aungst B. J. (1990) Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery. J. Pharmacol. Sci. 79, 771-772.
15. Inada T., Polk K., Jin C., Purser C., Hume A., Hoskins B., Ho I. K., and Rockhold R. W. (1992) Cocaine elevates striatal dopamine efflux in spontaneously hypertensive and Wistar-Kyoto rats. Brain Res. Bull. 28, 227-231.
16. Javaid J. I., Musa M. N., Fischman M., Schuster C. R., and Davis J. M. (1983) Kinetics of cocaine in humans after intravenous and intranasal administration. Biopharm. Drug Dispos. 4, 9-18.
17. Johanson C.-E. and Fischman M. W. (1989) The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41, 3-52.
18. Kao H. D., Itoh S., and Hussain A. (1994) Prodrugs of 1-DOPA for nasal administration. Pharm. Res. 11 (Suppl.), 288.
19. Kapoor R., Turjanski N., Frankel J., Kleedorfer B., Lees A., Stern G., Bovingdon M., and Webster R. (1990) Intranasal apomorphine: a new treatment in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 53, 1015.
20. Keller R. W., Maisonneuve I. M., Carlson J. N., and Click S. D. (1992) Within-subject sensitization of striatal dopamine release after a single injection of cocaine: an in vivo microdialysis study. Synapse 11, 28-34.
21. Koob G. F. (1992) Dopamine, addiction and reward. Semin. Neurosci. 4, 139-148.
22. Kuczenski R. and Segal D. (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphet-amine using in vivo microdialysis. J. Neurosci. 9, 2051-2065.
23. Kumar T. C. A., David G. F. X., Sankaranarayanan A., Puri V., and Sundram K. R. (1982) Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying. Proc. Natl. Acad. Sci. USA 79, 4185-4189.
24. Nicolaysen L. C., Pan H.-T., and Justice J. B. Jr. (1988) Extracellular cocaine and dopamine concentrations are linearly related in rat striatum. Brain Res. 456, 317-323.
25. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, Sydney.
26. Quinn N. P. (1984) Anti-parkinsonian drugs today. Drugs 28, 236-262.
27. Roll J. M., Kelly B. P., Benjamin F., and See R. D. (1994) A method for examining the operant self-administration of respirable pharmaceuticals in rodents. Behav. Res. Methods Instr. Comp. 26, 427-430.
28. Sakane T., Akizuki M., Yoshida M., Yamashita S., Nadai T., Hashida M., and Sezaki H. (1990) Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity. J. Pharm. Pharmacol. 43, 449-451.
29. Schwaning R. and Huston J. P. (1987) Dopamine and serotonin metabolism in brain sites ipsi- and contralateral to direction of conditioned turning in rats. J. Neurochem. 48, 1473-1479.
30. Segal D. S. and Kuczenski R. (1992) Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577, 351-355.
31. Sharp T., Zetterström T., Ljungberg T., and Ungerstedt U. (1987) A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401, 332-330.
32. Shipley M. T. (1985) Transport of molecules from nose to brain: transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res. Bull. 15, 129-142
33. Su K. S. E., Campanale K. M., Mendelsohn L. G., Kerchner G. A., and Gries C. L. (1985) Nasal delivery of polypeptides I: nasal absorption of enkephalins in rats. J. Pharm. Sci. 74, 394-398
34. Sweeney P. J. (1995) Parkinson's disease: managing symptoms and preserving function. Geriatrics 50, 24-31.
35. Thorne R. G., Emory C. R., Ala T. A., and Frey W. H. II. (1995) Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res. 692, 278-282.
36. van Laar T., Jansen E. N. H., Essink A. W. G., and Neef C. (1992) Intranasal apomorphine in parkinsonian on-off fluctuations. Arch. Neurol. 49, 482-484.
37. Wachtel S. R. and Abercrombie E. D. (1994) L-3,4-Dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors. J. Neurochem. 63, 108-117.
38. Wilkinson P., van Dyke C., Jatlow P., Barash P., and Byck R. (1980) Intranasal and oral cocaine kinetics. Clin. Pharmacol. Ther. 27, 386-394.
39. Wise R. A. and Rompre P.-P. (1989) Brain dopamine and reward. Annu. Rev. Psychol. 40, 191-225.
40. Zetterström T., Sharp T., and Ungerstedt U. (1986) Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur. J. Pharmacol. 132, 1-9.